Today — thanks to new drug combinations and autologous transplantation — multiple myeloma is a disease that can be kept under control for years. The key lies in the right sequence of treatment lines: which drugs to use first and which to keep in reserve for later. Anadolu’s Haematology-Oncology centre treats myeloma according to the latest international protocols.
With experience of more than 3,000 bone marrow transplants, the centre routinely performs autologous transplantation, which is considered the standard consolidation treatment in eligible patients.
Treatment methods at Anadolu
Induction treatment
Modern three- and four-drug combinations (proteasome inhibitors, immunomodulators, anti-CD38 antibodies) — achieving considerably deeper responses than older protocols.
Autologous transplantation
High-dose melphalan chemotherapy followed by reinfusion of the patient’s own stem cells — it prolongs remission in eligible patients; at an experienced centre it is a safe, standardised procedure.
Maintenance treatment
After transplantation, maintenance treatment prolongs the progression-free period; the regimen is chosen according to the level of risk.
Treatment of bone complications
Bisphosphonates/denosumab, vertebroplasty for vertebral fractures and targeted radiotherapy of painful lesions.
Treatments for relapse
For relapsed or refractory myeloma, new combinations and bispecific antibodies — at the decision of the multidisciplinary tumour board.
Why international patients choose Anadolu
- Affiliation with Johns Hopkins Medicine — shared clinical protocols with one of the largest medical centres in the United States.
- JCI, ESMO and OECI accreditations — internationally recognised quality and patient safety.
- Multidisciplinary tumour boards — your treatment plan is decided not by a single doctor but by a team of specialists.
- Support in English — a coordinator and an interpreter at every step, from your first enquiry to discharge.
- A transparent cost estimate before you travel — you know the estimated cost of treatment in advance.
- Practical assistance — our team assists with travel and, where needed, visa formalities.
Specialist doctors
Zafer Gülbaş
Professor of Internal Medicine and Haematology
Haematology-Oncology and Bone Marrow Transplantation
Sinan Karaaslan
Medical oncology physician
Medical OncologyHow to start your treatment
Send your records
Reports, scans and test results — via the form, by email or WhatsApp.
The doctor’s opinion
A specialist will review your case free of charge within 48 hours.
Plan and cost estimate
You will receive the treatment plan and its estimated cost — before you travel.
Arrival and treatment
Transfers, accommodation and an interpreter — everything is arranged by the hospital.
Frequently asked questions — multiple myeloma
Can multiple myeloma be cured?
A complete cure is rare, but modern treatments achieve deep remissions lasting several years and a good quality of life. The aim is to turn myeloma into a controlled chronic disease.
Who needs a transplant?
Most patients in good general health, up to about 70 years of age. It is an autologous transplant — the patient’s own cells are used, with no need for a donor.
I have back pain — could it be caused by myeloma?
Myeloma often affects the vertebrae. The hospital treats both the pain and its cause: vertebroplasty, irradiation of the lesions and systemic treatment are used together.
How long does the transplant take?
Stem cell collection and the high-dose phase require 4 to 5 weeks at the hospital in total, followed by outpatient follow-up.
How can I get a second opinion?
Send your protein electrophoresis, bone marrow biopsy result and imaging via the form or WhatsApp — the haematologist’s response reaches you within 48 hours.
Request a treatment plan and cost estimate
Free: a specialist will review your records within 48 hours.